US2021041427A1PendingUtilityA1
Methods and compositions for phototransfer
Est. expiryNov 6, 2027(~1.3 yrs left)· nominal 20-yr term from priority
G01N 33/54353G01N 33/54393G01N 33/54306C12Q 1/6806
75
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Methods are described for phototransferring a compound from a first surface to a second surface. Compounds are described with photocleavable linkers. Compounds attached to a first surface through a photocleavable linker are put in proximity (or contact) with a second surface, and then phototransferred to the second surface upon exposure to electromagnetic radiation. Illuminating the compound with radiation photocleaves the compound from the first surface and transfers the compound to the second surface.
Claims
exact text as granted — not AI-modified1 - 5 . (canceled)
6 . A method for concentrating a target analyte from a sample using photocleavable binding agents, comprising: a) providing: i. a sample comprising a target analyte, said sample being a heterogeneous mixture; ii. a plurality of binding agents attached to a surface through a photocleavable linker, wherein at least a portion of said binding agents are conjugated to a detectable label; and iii. a source of electromagnetic radiation; b) contacting said binding agents with said sample under conditions such that at least a portion of said binding agents bind said target analyte so as to make a complex; and c) illuminating said complex with radiation from said radiation source under conditions such that said complex, comprising a target analyte bound to said binding agent, is photocleaved from said surface and released into a solution under conditions such that the concentration of said target analyte in said solution is increased relative to said sample.
7 . The method of claim 6 , wherein said detectable label is a fluorescent label.
8 . The method of claim 6 , wherein said photocleavable linker is a photocleavable biotin.
9 . The method of claim 6 , wherein said sample is a biological fluid.
10 . The method of claim 6 , wherein said sample is a body fluid from a mammal.
11 . The method of claim 10 , wherein said body fluid is selected from the group consisting of blood, serum and plasma.
12 . The method of claim 6 , wherein said target analyte is a peptide or protein.
13 . The method of claim 6 , wherein said binding agent is an antibody.
14 . The method of claim 6 , wherein said binding agent is an aptamer or a modified aptamer.
15 . The method of claim 6 , wherein said surface is the surface of a bead or microsphere.
16 . The method of claim 6 , wherein said surface is the surface of a microtiter plate.
17 . The method of claim 6 , wherein said surface is the surface of a membrane.
18 . The method of claim 17 , wherein said membrane is comprised of nitrocellulose, cellulose nitrate, cellulose acetate and/or mixed cellulose esters.
19 . A method for purifying a target analyte from a sample using photocleavable binding agents, comprising: a) providing: i. a sample comprising a target analyte, said sample being a heterogeneous mixture; ii. a plurality of binding agents attached to a surface through a photocleavable linker, wherein at least a portion of said binding agents are conjugated to a detectable label; and iii. a source of electromagnetic radiation; b) contacting said binding agents with said sample under conditions such that at least a portion of said binding agents bind said target analyte so as to make a complex; and c) illuminating said complex with radiation from said radiation source under conditions such that said complex, comprising a target analyte bound to said binding agent, is photocleaved from said surface and released into a solution under conditions such that the purity of said target analyte in said solution is increased relative to said sample.
20 . The method of claim 19 , wherein said detectable label is a fluorescent label.
21 . The method of claim 19 , wherein said photocleavable linker is a photocleavable biotin.
22 . The method of claim 19 , wherein said sample is a biological fluid.
23 . The method of claim 19 , wherein said sample is a body fluid from a mammal.
24 . The method of claim 23 , wherein said body fluid is selected from the group consisting of blood, serum and plasma.
25 . The method of claim 19 , wherein said target analyte is a peptide or protein.
26 . The method of claim 19 , wherein said binding agent is an antibody.
27 . The method of claim 19 , wherein said binding agent is an aptamer or a modified aptamer.
28 . The method of claim 19 , wherein said surface is the surface of a bead or microsphere.
29 . The method of claim 19 , wherein said surface is the surface of a microtiter plate.
30 . The method of claim 19 , wherein said surface is the surface of a membrane.
31 . The method of claim 30 , wherein said membrane is comprised of nitrocellulose, cellulose nitrate, cellulose acetate and/or mixed cellulose esters.
32 . A method for detecting a target analyte from a sample using photocleavable binding agents, comprising: a) providing: i. a sample comprising a target analyte, said sample being a heterogeneous mixture; ii. a plurality of binding agents attached to a surface through a photocleavable linker, wherein at least a portion of said binding agents are conjugated to a detectable label; and iii. a source of electromagnetic radiation; b) contacting said binding agents with said sample under conditions such that at least a portion of said binding agents bind said target analyte so as to make a complex; c) illuminating said complex with radiation from said radiation source under conditions such that said complex, comprising a target analyte bound to said binding agent, is photocleaved from said surface and released; and d) detecting said target analyte.
33 . The method of claim 32 , wherein said detectable label is a fluorescent label.
34 . The method of claim 32 , wherein said photocleavable linker is a photocleavable biotin.
35 . The method of claim 32 , wherein said sample is a biological fluid.
36 . The method of claim 32 , wherein said sample is a body fluid from a mammal.
37 . The method of claim 36 , wherein said body fluid is selected from the group consisting of blood, serum and plasma.
38 . The method of claim 32 , wherein said target analyte is a peptide or protein.
39 . The method of claim 32 , wherein said binding agent is an antibody.
40 . The method of claim 32 , wherein said binding agent is an aptamer or a modified aptamer.
41 . The method of claim 32 , wherein said surface is the surface of a bead or microsphere.
42 . The method of claim 32 , wherein said surface is the surface of a microtiter plate.
43 . The method of claim 32 , wherein said surface is the surface of a membrane.
44 . The method of claim 43 , wherein said membrane is comprised of nitrocellulose, cellulose nitrate, cellulose acetate and/or mixed cellulose esters.
45 . The method of claim 32 , wherein said detecting is performed using solid-phase immunoassay.
46 . A composition comprising: a plurality of binding agents attached to a surface through a photocleavable linker, at least a portion of said binding agents conjugated to a detectable label.
47 . The composition of claim 46 , wherein said detectable label is a fluorescent label.
48 . The composition of claim 46 , wherein said binding agent is an antibody.
49 . The composition of claim 46 , wherein said binding agent is an aptamer or a modified aptamer.
50 . The composition of claim 46 , wherein said surface is the surface of a bead or microsphere.
51 . The composition of claim 46 , wherein said surface is the surface of a microtiter plate.
52 . The composition of claim 46 , wherein said surface is the surface of a membrane.
53 . The composition of claim 52 , wherein said membrane is comprised of nitrocellulose, cellulose nitrate, cellulose acetate and/or mixed cellulose esters.Join the waitlist — get patent alerts
Track US2021041427A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.